New insights into atypical Alzheimer's disease in the era of biomarkers
Most patients with Alzheimer's disease present with amnestic problems; however, a
substantial proportion, over-represented in young-onset cases, have atypical phenotypes …
substantial proportion, over-represented in young-onset cases, have atypical phenotypes …
[HTML][HTML] Imaging biomarkers in neurodegeneration: current and future practices
PNE Young, M Estarellas, E Coomans… - Alzheimer's research & …, 2020 - Springer
There is an increasing role for biological markers (biomarkers) in the understanding and
diagnosis of neurodegenerative disorders. The application of imaging biomarkers …
diagnosis of neurodegenerative disorders. The application of imaging biomarkers …
[HTML][HTML] EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
The present procedural guidelines summarize the current views of the EANM Neuro-
Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …
Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies
KA Jellinger - Journal of neural transmission, 2018 - Springer
Dementia with Lewy bodies (DLB) and Parkinson's disease-dementia (PDD), although
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …
sharing many clinical, neurochemical and morphological features, according to DSM-5, are …
18F-FDG PET imaging in neurodegenerative dementing disorders: insights into subtype classification, emerging disease categories, and mixed dementia with …
S Minoshima, D Cross, T Thientunyakit… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Since the invention of 18 F-FDG as a neurochemical tracer in the 1970s, 18 F-FDG PET has
been used extensively for dementia research and clinical applications. FDG, a glucose …
been used extensively for dementia research and clinical applications. FDG, a glucose …
Hallucinations, somatic‐functional disorders of PD‐DLB as expressions of thalamic dysfunction
M Onofrj, AJ Espay, L Bonanni, S Delli Pizzi… - Movement …, 2019 - Wiley Online Library
Hallucinations, delusions, and functional neurological manifestations (conversion and
somatic symptom disorders) of Parkinson's disease (PD) and dementia with Lewy bodies …
somatic symptom disorders) of Parkinson's disease (PD) and dementia with Lewy bodies …
Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease
JL Whitwell, J Graff-Radford, N Tosakulwong… - Alzheimer's & …, 2018 - Elsevier
Introduction Neuroimaging modalities can measure different aspects of the disease process
in Alzheimer's disease, although the relationship between these modalities is unclear …
in Alzheimer's disease, although the relationship between these modalities is unclear …
[HTML][HTML] Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria
Abstract Background [18F] FDG-PET hypometabolism patterns are indicative of different
neurodegenerative conditions, even from the earliest disease phase. This makes [18F] FDG …
neurodegenerative conditions, even from the earliest disease phase. This makes [18F] FDG …
[HTML][HTML] Diagnosis and management of posterior cortical atrophy
KXX Yong, J Graff-Radford, S Ahmed… - … treatment options in …, 2023 - Springer
Purpose of review The study aims to provide a summary of recent developments for
diagnosing and managing posterior cortical atrophy (PCA). We present current efforts to …
diagnosing and managing posterior cortical atrophy (PCA). We present current efforts to …
Breakdown of specific functional brain networks in clinical variants of Alzheimer's disease
Alzheimer's disease (AD) is characterized by different clinical entities. Although AD
phenotypes share a common molecular substrate (ie, amyloid beta and tau accumulation) …
phenotypes share a common molecular substrate (ie, amyloid beta and tau accumulation) …